RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Neurobiological Technologies - Stock

Neurobiological Technologies Employees 2024

Neurobiological Technologies Employees

0

Ticker

NTII

ISIN

US64124W3043

WKN

A0M1WB

In 2024, Neurobiological Technologies employed 0 people, a 0% change from the 0 number of employees in the previous year.

Neurobiological Technologies Aktienanalyse

What does Neurobiological Technologies do?

Neurobiological Technologies Inc. (NTI) is an American company specializing in the research and development of new drugs for neurological disorders. It was founded in the 1980s by a team of neuroscientists focused on the treatment of stroke and traumatic brain injuries. NTI's business model is based on identifying promising targets within the nervous system and developing novel drugs that specifically target these targets. Through close collaboration with academic and clinical partners, NTI can rapidly develop new technologies and therapeutic approaches and bring them into the clinical phase. NTI is divided into various divisions focusing on different neurological disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. Each division is staffed with experts who have extensive experience in their respective research fields and collaborate closely with external partners. Over the years, NTI has developed several products at different stages of clinical development. One of the most promising products is XERECEPT, a synthetic peptide used for the treatment of brain tumors. The drug has shown promising results in clinical trials and has been submitted for market approval in the USA and Europe. Another promising product is Viprinex, a novel medication for the treatment of stroke patients. Viprinex is currently being tested in phase III of clinical development, and the results of the clinical trials are promising, suggesting that the drug may be approved in the near future. NTI is a pioneer in the field of neurology and has received several awards and accolades for its work. The company is also recognized in the academic community and has established partnerships with leading universities and research institutions. Overall, NTI is an innovative company specializing in the development of novel drugs for neurological disorders. It has achieved impressive successes in recent decades and is considered one of the most promising development companies in the field of neurology. Neurobiological Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Neurobiological Technologies's Employee Base

Neurobiological Technologies's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Neurobiological Technologies's operational capacity and future potential.

Year-to-Year Comparison

Assessing Neurobiological Technologies's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Neurobiological Technologies's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Neurobiological Technologies’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Neurobiological Technologies Stock

How many employees does Neurobiological Technologies have this year?

Neurobiological Technologies has 0 undefined employees this year.

How many employees did Neurobiological Technologies have compared to the previous year?

Compared to the previous year, Neurobiological Technologies had 0% more employees.

What impact did the number of employees have on the company Neurobiological Technologies?

The number of employees has a direct impact on the efficiency and productivity of Neurobiological Technologies. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Neurobiological Technologies?

The number of employees can also have an impact on investors of Neurobiological Technologies, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Neurobiological Technologies affect the company?

An increase in equity of Neurobiological Technologies can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Neurobiological Technologies's equity affect the company?

A reduction in equity of Neurobiological Technologies can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Neurobiological Technologies?

Some factors that can influence the equity of Neurobiological Technologies include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Neurobiological Technologies so important for investors?

The equity of Neurobiological Technologies is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Neurobiological Technologies influence the company?

The number of employees at Neurobiological Technologies can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Neurobiological Technologies evolved in recent years?

In recent years, the number of employees at Neurobiological Technologies has changed by NaN.

How many employees does Neurobiological Technologies currently have?

Neurobiological Technologies currently has 0 undefined employees.

Why is the number of employees important for investors of Neurobiological Technologies?

The number of employees is important for investors of Neurobiological Technologies as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Neurobiological Technologies take to change the number of employees?

To change the number of employees, Neurobiological Technologies can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Neurobiological Technologies pay?

Over the past 12 months, Neurobiological Technologies paid a dividend of 0.93 USD . This corresponds to a dividend yield of about 930,000 %. For the coming 12 months, Neurobiological Technologies is expected to pay a dividend of 0.93 USD.

What is the dividend yield of Neurobiological Technologies?

The current dividend yield of Neurobiological Technologies is 930,000 %.

When does Neurobiological Technologies pay dividends?

Neurobiological Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Neurobiological Technologies?

Neurobiological Technologies paid dividends every year for the past 0 years.

What is the dividend of Neurobiological Technologies?

For the upcoming 12 months, dividends amounting to 0.93 USD are expected. This corresponds to a dividend yield of 930,000 %.

In which sector is Neurobiological Technologies located?

Neurobiological Technologies is assigned to the '-' sector.

Wann musste ich die Aktien von Neurobiological Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Neurobiological Technologies from 12/27/2012 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2012.

When did Neurobiological Technologies pay the last dividend?

The last dividend was paid out on 12/27/2012.

What was the dividend of Neurobiological Technologies in the year 2023?

In the year 2023, Neurobiological Technologies distributed 0 USD as dividends.

In which currency does Neurobiological Technologies pay out the dividend?

The dividends of Neurobiological Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Neurobiological Technologies

Our stock analysis for Neurobiological Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neurobiological Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.